Average Co-Inventor Count = 2.29
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. The Mathilda and Terence Kennedy Institute of Rheumatology Trust (4 from 7 patents)
2. The Kennedy Institute of Rheumatology (3 from 4 patents)
3. The Kennedy Institute for Rheumatology (1 from 1 patent)
4. The Mathilda and Terrence Kennedy Institute of Rheumatology Trust (0 patent)
8 patents:
1. 8383120 - Concomitant treatment of rheumatoid arthritis with anti-TNF-alpha antibodies and methotrexate
2. 8298537 - Concomitant treatment of rheumatoid arthritis with anti-TNF-α antibodies and methotrexate
3. 7846442 - Methods of treating rheumatoid arthritis with an anti-TNF-alpha antibodies and methotrexate
4. 7838489 - Methods of treating rheumatoid arthritis with p75 TNF-alpha receptor and methotrexate
5. 7608262 - Methods of preventing or treating thrombosis with tumor necrosis factor antagonists
6. 6770279 - TNF&agr; antagonists and cyclosporin in therapy of rheumatoid arthritis
7. 6270766 - Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease
8. 5741488 - Treatment of rheumatoid arthritis with anti-CD4 antibodies in